BDK Advokati’s counsel Bisera Andrijašević and junior associate Anja Gligorević authored the chapter on Serbia featured among 19 jurisdictions in the 2022 edition of the Chambers’ Global Practice Guide on Life Sciences.
The Serbian chapter gives an overview of the regulatory regime for the life sciences sector in Serbia, offering information on the topics such as the challenging the decisions of regulatory bodies, conduct of clinical trials and related data protection issues, the marketing, manufacturing and distribution of pharmaceuticals and medical devices, pricing of medicines, digital healthcare, and patents. The chapter also analyses the developments related to COVID-19 crises.
The Serbian chapter of the Chambers Life Sciences 2022 Global Practice Guide can be viewed here.
To access the entire guide online, use the following link: Life Sciences 2022.
